CME, S&P explore sale of joint venture OSTTRA, Bloomberg News reports

(Reuters) - Derivatives exchange CME Group (NASDAQ:CME ) and financial information company S&P Global are weighing a sale of joint venture OSTTRA, Bloomberg News reported on Thursday, citing people familiar with the matter.

The two companies are in talks with financial advisers to find buyers for the JV, which could be valued between $2 billion and $4 billion, including debt, as per the report.

CME declined to comment on the matter, while S&P did not immediately respond to a Reuters' request for the same.

OSTTRA, a post-trade services company, was launched by CME and analytics firm IHS Markit in September 2021.

The JV, owned equally by CME and IHS Markit at that time, provides post-trade solutions for the global over-the-counter markets across interest rate, FX, equity and credit asset classes.



S&P Global completed the acquisition of IHS Markit in February 2022.

The report, however, added that there is no certainty of a transaction.

Source: Investing.com